# Entrada Therapeutics, Inc. — Form D

Entrada Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-10. The offering totals $1.6M, of which $600K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-11-10
- Form: D
- Accession: 0001689375-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $600K
- Remaining: $1000K
- Investors: 2
- Date of first sale: 2016-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274261

## Issuer

- Name: Entrada Therapeutics, Inc.
- CIK: 0001689375
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 6 TIDE STREET, BOSTON, MA, 02210
- Phone: 857-305-1825

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| Kush Parmar | Executive Officer | San Francisco, CA |
| Louis Tartaglia | Executive Officer | BOSTON, MA |
| Louis Tartaglia | Director | BOSTON, MA |
| Todd Foley | Director | South San Francisco, CA |
| John F Crowley | Director | Princeton, NJ |
| Mario Saltarelli | Executive Officer | Newport Beach, CA |
| Christine Brennan | Director | Watertown, MA |
| Kush M Parmar | Director | Boston, MA |
| John Crowley | Director | Alameda, CA |
| Carole F Nuechterlein | Director | Boston, MA |
| Natarajan F Sethuraman | Executive Officer | Boston, MA |
| Todd F Foley | Director | Boston, MA |
| Peter F Kim | Director | Boston, MA |
| Nerissa F Kreher | Executive Officer | Boston, MA |
| Kory F Wentworth | Executive Officer | Boston, MA |
| Dipal Doshi | Director | Boston, MA |
| Dipal Doshi | Executive Officer | Boston, MA |
| Nathan F Dowden | Executive Officer | Boston, MA |
| Kush Parmar | Director | San Francisco, CA |
| Natarajan Sethuraman | Executive Officer | Boston, MA |
| Nathan Dowden | Executive Officer | Boston, MA |
| Anja Harmeier | Director | Boston, MA |
| Dehua Pei | Director | Boston, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-04-13](https://search.stillhousedata.com/formd/0001689375-21-000002) | D | $116.2M | $116.2M |
| [2019-12-26](https://search.stillhousedata.com/formd/0001689375-19-000002) | D/A | $59.0M | $34.0M |
| [2018-12-26](https://search.stillhousedata.com/formd/0001531209-18-000003) | D | $59.0M | $34.0M |

## More

- [CIK 1689375 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1689375&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001689375-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.